A yak bone collagen peptide for osteoporosis prevention, its preparation method and application
Collagen peptides prepared by stepwise enzymatic hydrolysis and metal ion composite technology have solved the problems of low enzymatic hydrolysis efficiency and insufficient mineral element supplementation, realizing the synergistic effect of collagen peptides and mineral elements, and enhancing the anti-osteoporosis effect.
Patent Information
- Application Number
- CN202611374987.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-07
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2046-09-07
AI Technical Summary
Existing methods for preparing collagen peptides suffer from problems such as low enzymatic hydrolysis efficiency, uneven peptide molecular weight distribution, and insufficient mineral element supplementation, resulting in limited anti-osteoporosis effects.
Using stepwise enzymatic hydrolysis and metal ion complexation technology, small molecule collagen peptides are prepared by alkaline and neutral enzymatic hydrolysis, and then complexed with calcium salts and strontium salts to form collagen peptide-calcium-strontium complexes, which promote bone formation and mineralization.
It improves the enzymatic hydrolysis efficiency of collagen peptides and the binding stability of mineral elements, realizing the synergistic effect of collagen peptides and mineral elements, and enhancing the anti-osteoporosis effect.
Smart Images

Figure CN122855601B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of bioactive peptide technology, and in particular to an anti-osteoporosis yak bone collagen peptide, its preparation method, and its application. Background Technology
[0002] Osteoporosis is a metabolic bone disease characterized by decreased bone mass, destruction of bone microstructure, and increased bone fragility. It significantly increases the risk of fractures and severely impacts the quality of life for middle-aged and elderly individuals, especially postmenopausal women and the elderly population. Bone tissue is primarily composed of an organic matrix and inorganic minerals. The organic matrix is mainly composed of type I collagen, while the inorganic component is primarily calcium salts. Bone formation, mineralization, and remodeling depend on the synergistic effect of collagen matrix support and mineral element deposition. Therefore, developing bone health products that combine collagen nutritional support and mineral supplementation has become an important research direction in the field of osteoporosis prevention.
[0003] Currently, products on the market for improving bone health mainly include calcium supplements, vitamin D supplements, and collagen products. While calcium supplements can replenish the raw materials needed for bone mineralization, they generally suffer from limited absorption and utilization, easy precipitation with other components in the gastrointestinal tract, and a single form of supplementation. On the other hand, collagen or collagen peptides, as an important source of bone matrix, have the potential to promote bone matrix formation and improve the bone metabolic environment. However, single collagen products usually focus on providing organic matrix nutritional support, and are insufficient in synergistic supplementation of key elements for bone mineralization. Therefore, their overall effect in preventing osteoporosis remains limited.
[0004] Animal bones, especially bovine and yak bones, are rich in type I collagen and natural minerals, making them important raw materials for preparing bone-derived collagen peptides. Compared to ordinary bovine bones, yak bones are naturally derived and have higher development and utilization value. However, the internal structure of yak bones is relatively dense, and collagen usually forms a stable complex structure with bone marrow fat, non-collagenous impurities, and inorganic minerals such as hydroxyapatite, making it difficult to release collagen. Traditional processes, such as direct extraction or enzymatic hydrolysis, often suffer from low enzymatic hydrolysis efficiency, uneven peptide molecular weight distribution, and low yield of target active peptides. Existing methods for preparing bone-derived collagen peptides typically employ simple crushing, defatting, and single enzymatic hydrolysis processes. However, due to insufficient pretreatment, the encapsulation and shielding effects of fat and minerals in the bone on collagen are difficult to effectively eliminate, making it difficult to fully loosen collagen fibers. This results in insufficient exposure of natural enzyme cleavage sites and potential active groups, thereby limiting the efficiency of subsequent enzymatic hydrolysis reactions and the proportion of small molecule peptides generated. In particular, single-protease treatment methods often struggle to simultaneously achieve rapid disruption of the collagen macromolecular structure and precise preparation of low-molecular-weight active peptides, resulting in a low proportion of peptides smaller than 1000 Da in the final product, which is detrimental to human absorption and functional performance. Furthermore, during collagen heat treatment, excessive protein denaturation, aggregation, and even impairment of functional group activity often occur, affecting subsequent enzymatic hydrolysis and product quality. While some methods utilize ultrasound or heat treatment to promote collagen structure disintegration, they lack effective control over collagen's thermal stability and dispersibility, making it difficult to achieve the ideal state of "moderate unfolding without excessive aggregation," thus impacting the preparation of small-molecule active peptides. Moreover, most existing collagen peptide products only focus on preparing the small-molecule peptides themselves, lacking effective composite design for key bone health minerals such as calcium. Even when mineral elements are added, they are mostly simple physical mixtures that fail to fully utilize the natural active sites such as carboxyl, amino, hydroxyl, and carbonyl groups in collagen peptide molecules to form a relatively stable bond with mineral elements. As a result, there are defects such as poor dispersion of mineral elements, high proportion of free ions, insufficient stability, and limited bioavailability potential, making it difficult to achieve synergistic effects between collagen peptides, organic matrix support, and bone mineralization element supplementation.
[0005] To address the above technical problems, this invention provides an anti-osteoporosis yak bone collagen peptide and its preparation method. Summary of the Invention
[0006] The purpose of this invention is to provide an anti-osteoporosis yak bone collagen peptide, its preparation method, and its application. This invention involves a complex reaction of small-molecule yak bone collagen peptides with calcium salts and strontium salts, allowing the exposed natural active sites in the peptide chain to react with calcium salts. 2+ 、Sr 2+The combination forms a collagen peptide-calcium-strontium complex. The three components work synergistically to promote bone formation, support bone mineralization, and improve bone metabolism. Therefore, compared to single collagen peptides or single mineral supplements, it has greater potential for anti-osteoporosis applications.
[0007] To achieve the above objectives, the present invention provides a method for preparing yak bone collagen peptides for osteoporosis prevention, comprising the following steps: Step 1, Yak bone pretreatment: Take yak bones, wash them to remove blood and impurities, and crush the yak bones to 0.5-5cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; Degreasing can remove bone marrow fat and non-target hydrophobic impurities, reduce the encapsulation and shielding of collagen by lipids, and improve the subsequent collagen exposure process. Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. After demineralization, they are washed with deionized water until they are close to neutral. Collagen in yak bone forms a dense composite structure with inorganic minerals such as hydroxyapatite; demineralization can remove inorganic salts that embed collagen fibers, making the collagen fibers loose and increasing the exposure of natural active sites during subsequent thermal denaturation, ultrasonication and enzymatic hydrolysis. Step 4, heat denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water, add trehalose as a protective agent, and carry out heat denaturation treatment; Thermal denaturation can disrupt the hydrogen bonds and some non-covalent interactions in the triple helix structure of collagen, causing the collagen chains to unfold and exposing internal enzyme cleavage sites and potential metal-binding groups. At the same time, trehalose, as a heat protectant, can stabilize the hydration layer around collagen, reduce heat-induced irreversible aggregation and excessive denaturation, and promote the moderate unfolding of collagen molecules during heat treatment. This is beneficial for exposing enzyme cleavage sites and potential metal-binding groups, and also helps to maintain the dispersibility of collagen chains and the activity of functional groups, thereby improving the efficiency of subsequent enzymatic hydrolysis and the functional quality of the product. Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400 W, time 30 min, temperature control not higher than 60℃. Ultrasonic cavitation and shearing can further loosen collagen fiber aggregates and increase the accessibility of natural active sites and enzyme cleavage sites such as carboxyl, amino, carbonyl, and hydroxyl groups in collagen molecules. Step 6, stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8%, first perform alkaline protease hydrolysis, and then perform neutral protease hydrolysis; Stepwise enzymatic hydrolysis has a dual function: it degrades yak bone collagen into small-molecule collagen peptides; and it releases and exposes the calcium / strontium binding sites and osteogenic-related active peptide sequences that were originally hidden in the collagen. Alkaline protease is mainly used to rapidly open the large-molecule collagen structure, while neutral protease further cleaves the unfolded peptides, increasing the proportion of peptides smaller than 1000 Da. Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ① First, remove macromolecules using a 3 kDa ultrafiltration membrane; ② Then fractionate using a 1 kDa ultrafiltration membrane; collect the fractions smaller than 1 kDa; The obtained yak bone collagen peptides have a molecular weight of less than 1000 Da; the proportion of peptides with a molecular weight of less than 1000 Da is ≥90%. Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a concentration less than 1000 Da is reacted with calcium and strontium salts to allow the exposed natural active sites to react with the calcium ions. 2+ 、Sr 2+ After the complex reaction is completed, unbound or free calcium and strontium ions are removed to obtain a complex solution; wherein, the mass ratio of yak bone collagen peptide, calcium salt, and strontium salt is yak bone collagen peptide: calcium salt: strontium salt = 100: 5-80: 0.1-20. Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
[0008] Further, in step 1, the yak bone is the long bone, rib, spine, or a mixture thereof of yak; broken to 1-3 cm.
[0009] Furthermore, in step 2, the degreasing treatment uses hot water degreasing or ethanol-assisted degreasing. The hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; the ethanol-assisted degreasing conditions are: ethanol volume fraction 20%, temperature 50℃, time 2h; in step 3, the acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h.
[0010] Furthermore, in step 4, the heat denaturation treatment conditions are: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5; the amount of trehalose added is 3.0% w / v.
[0011] Furthermore, in step 6, ① the alkaline protease hydrolysis conditions are: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ② Neutral protease hydrolysis, under the following conditions: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, time 1 h.
[0012] Further, in step 9, the calcium salt is calcium chloride, calcium lactate, calcium gluconate, calcium citrate, or calcium acetate; preferably calcium chloride or calcium lactate; the strontium salt is strontium chloride, strontium lactate, strontium gluconate, or strontium acetate; preferably strontium chloride or strontium lactate.
[0013] Further, in step 9, the composite reaction conditions are as follows: yak bone collagen peptide solution mass concentration 3%-6%, pH 6.8-7.2, temperature 45-55℃, time 40-60 min; the mass ratio of yak bone collagen peptide, calcium salt, and strontium salt is yak bone collagen peptide: calcium salt: strontium salt = 100:20-60:1-10.
[0014] Furthermore, the present invention also provides an anti-osteoporosis yak bone collagen peptide, which is prepared by the above-described preparation method.
[0015] Furthermore, the present invention also provides the application of the above-mentioned yak bone collagen peptides in the preparation of anti-osteoporosis compositions.
[0016] Furthermore, the present invention also provides a yak bone collagen peptide composition for combating osteoporosis, wherein the yak bone collagen peptide composition comprises, by weight, 10-30 parts of the above-mentioned yak bone collagen peptide, 10-15 parts of isomaltooligosaccharide, 5-10 parts of resistant dextrin, 5-15 parts of erythritol, 0.5-2 parts of citric acid, 0.5-2 parts of vitamin D3, and 0.5-2 parts of vitamin K2.
[0017] The advantages and positive effects of the yak bone collagen peptide for osteoporosis prevention, its preparation method, and its application described in this invention are as follows: 1. In this invention, trehalose is added as a protective agent during the heat denaturation process. On the one hand, heat denaturation can destroy the hydrogen bonds and some non-covalent interactions in the triple helix structure of collagen, allowing the collagen chains to unfold appropriately and expose internal enzyme cleavage sites and potential metal-binding groups. On the other hand, trehalose can stabilize the hydration layer around the collagen, reduce irreversible aggregation and excessive denaturation caused by heat treatment, so that the collagen can achieve moderate unwinding without excessive inactivation during the heating process. This is beneficial to improving the efficiency of subsequent enzymatic hydrolysis and also helps to maintain the activity of functional groups and product quality.
[0018] 2. This invention involves a complex reaction between yak bone collagen peptides with a content less than 1000 Da and calcium and strontium salts, allowing the exposed natural active sites such as carboxyl, amino, hydroxyl, and carbonyl groups in the peptide chain to react with the calcium salts. 2+ 、Sr 2+ These components combine to form a collagen peptide-calcium-strontium complex. This complex allows collagen peptides to function not only as functional peptides but also as carriers of mineral elements, facilitating synergistic effects of collagen peptides, calcium, and strontium in promoting bone health. Simultaneously, collagen peptides provide peptide support for bone matrix formation, calcium serves as an important element for bone mineralization, and strontium participates in bone metabolism regulation. The combination of these three components creates a synergistic effect in promoting bone formation, supporting bone mineralization, and improving bone metabolism. Therefore, compared to single collagen peptides or single mineral supplements, it has greater potential for application in combating osteoporosis.
[0019] The technical solution of the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. Attached Figure Description
[0020] Figure 1 The above are the fluorescence intensity results of zebrafish skulls in this embodiment of the invention, where A is a fluorescence intensity image and B is the statistical result of fluorescence intensity. Figure 2 The results of bone calcium and bone mineral density in rats in this embodiment of the invention are shown, where A is bone calcium content, B is bone mineral density at the midpoint of the femur, and C is bone mineral density at the distal end of the femur. Detailed Implementation
[0021] The technical solution of the present invention will be further described below with reference to the accompanying drawings and embodiments.
[0022] Unless otherwise defined, the technical or scientific terms used in this invention shall have the ordinary meaning as understood by one of ordinary skill in the art to which this invention pertains.
[0023] Based on the embodiments of this invention, all other embodiments obtained by those skilled in the art without inventive effort are within the scope of protection of this invention. Experimental methods in the following embodiments that do not specify specific conditions are generally determined according to national standards. Experimental instruments, equipment, and reagents in the following embodiments that do not specify their sources are all commercially available materials.
[0024] Unless otherwise defined or stated, all technical and scientific terms used in this invention have the same meaning as those skilled in the art. Furthermore, any methods and materials similar to or equivalent to those described herein may be applied to the methods of this invention.
[0025] In this invention, the alkaline protease product number is A3377CAS 9014-01-1, and the neutral protease product number is A3469 (neutral protease, CAS 9068-59-1); both were purchased from Beijing Kangruina Biotechnology Co., Ltd.
[0026] Example 1 A method for preparing yak bone collagen peptides for osteoporosis prevention includes the following steps: Step 1, Yak bone pretreatment: Take the long bones, ribs and spine of the yak, clean them to remove blood and impurities, and crush the yak bones to 1-3 cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; the degreasing treatment is carried out by hot water degreasing, and the hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. The acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h. After demineralization, the bones are washed with deionized water until they are close to neutral. Step 4, thermal denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water, add trehalose as a protective agent, and carry out thermal denaturation treatment; the thermal denaturation treatment conditions are: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5, and the amount of trehalose added is 3.0% w / v. Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400 W, time 30 min, temperature control not higher than 60℃. Step 6, Stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8% and perform stepwise enzymatic hydrolysis; ①The alkaline protease hydrolysis conditions were: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ②The conditions for neutral protease hydrolysis were: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, and time 1 h; Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ① First, remove macromolecules using a 3 kDa ultrafiltration membrane; ② Then fractionate using a 1 kDa ultrafiltration membrane; collect the fractions smaller than 1 kDa; The obtained yak bone collagen peptides have a molecular weight of less than 1000 Da; the proportion of peptides with a molecular weight of less than 1000 Da is ≥90%. Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a concentration less than 1000 Da is reacted with calcium chloride salt and strontium lactate salt to allow the exposed natural active sites to react with Ca. 2+ 、Sr 2+ The reaction conditions were as follows: yak bone collagen peptide solution mass concentration 5%; pH 6.8-7.2; temperature 50℃; time 60 min; mass ratio of yak bone collagen peptide, calcium salt, and strontium salt was yak bone collagen peptide: calcium salt: strontium salt = 100:20:2; after the reaction was completed, unbound or free calcium ions and strontium ions were removed to obtain a complex solution. Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
[0027] Example 2 A method for preparing yak bone collagen peptides for osteoporosis prevention includes the following steps: Step 1, Yak bone pretreatment: Take the long bones, ribs and spine of the yak, clean them to remove blood and impurities, and crush the yak bones to 1-3 cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; the degreasing treatment is carried out by hot water degreasing, and the hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. The acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h. After demineralization, the bones are washed with deionized water until they are close to neutral. Step 4, thermal denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water, add trehalose as a protective agent, and carry out thermal denaturation treatment; the thermal denaturation treatment conditions are: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5, and the amount of trehalose added is 3.0% w / v. Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400 W, time 30 min, temperature control not higher than 60℃. Step 6, Stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8% and perform stepwise enzymatic hydrolysis; ①The alkaline protease hydrolysis conditions were: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ②The conditions for neutral protease hydrolysis were: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, and time 1 h; Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ① First, remove macromolecules using a 3 kDa ultrafiltration membrane; ② Then fractionate using a 1 kDa ultrafiltration membrane; collect the fractions smaller than 1 kDa; The obtained yak bone collagen peptides have a molecular weight of less than 1000 Da; the proportion of peptides with a molecular weight of less than 1000 Da is ≥90%. Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a concentration less than 1000 Da is reacted with calcium chloride salt and strontium lactate salt to allow the exposed natural active sites to react with Ca. 2+ 、Sr 2+ The reaction conditions were as follows: yak bone collagen peptide solution mass concentration 5%; pH 6.8-7.2; temperature 50℃; time 60 min; mass ratio of yak bone collagen peptide, calcium salt, and strontium salt was yak bone collagen peptide: calcium salt: strontium salt = 100:25:2; after the reaction was completed, unbound or free calcium ions and strontium ions were removed to obtain a complex solution. Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
[0028] Example 3 A method for preparing yak bone collagen peptides for osteoporosis prevention includes the following steps: Step 1, Yak bone pretreatment: Take the long bones, ribs and spine of the yak, clean them to remove blood and impurities, and crush the yak bones to 1-3 cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; the degreasing treatment is carried out by hot water degreasing, and the hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. The acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h. After demineralization, the bones are washed with deionized water until they are close to neutral. Step 4, thermal denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water, add trehalose as a protective agent, and carry out thermal denaturation treatment; the thermal denaturation treatment conditions are: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5, and the amount of trehalose added is 3.0% w / v. Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400 W, time 30 min, temperature control not higher than 60℃. Step 6, Stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8% and perform stepwise enzymatic hydrolysis; ①The alkaline protease hydrolysis conditions were: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ②The conditions for neutral protease hydrolysis were: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, and time 1 h; Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ① First, remove macromolecules using a 3 kDa ultrafiltration membrane; ② Then fractionate using a 1 kDa ultrafiltration membrane; collect the fractions smaller than 1 kDa; The obtained yak bone collagen peptides have a molecular weight of less than 1000 Da; the proportion of peptides with a molecular weight of less than 1000 Da is ≥90%. Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a concentration less than 1000 Da is reacted with calcium chloride salt and strontium lactate salt to allow the exposed natural active sites to react with Ca. 2+ 、Sr 2+ The reaction conditions were as follows: yak bone collagen peptide solution mass concentration 5%; pH 6.8-7.2; temperature 50℃; time 60 min; mass ratio of yak bone collagen peptide, calcium salt, and strontium salt was yak bone collagen peptide: calcium salt: strontium salt = 100:30:3; after the reaction was completed, unbound or free calcium ions and strontium ions were removed to obtain a complex solution. Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
[0029] Comparative Example 1 A method for preparing yak bone collagen peptides for osteoporosis prevention includes the following steps: Step 1, Yak bone pretreatment: Take the long bones, ribs and spine of the yak, clean them to remove blood and impurities, and crush the yak bones to 1-3 cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; the degreasing treatment is carried out by hot water degreasing, and the hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. The acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h. After demineralization, the bones are washed with deionized water until they are close to neutral. Step 4, thermal denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water without adding trehalose, and perform thermal denaturation treatment; the thermal denaturation treatment conditions are: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5. Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400 W, time 30 min, temperature control not higher than 60℃. Step 6, Stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8% and perform stepwise enzymatic hydrolysis; ①The alkaline protease hydrolysis conditions were: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ②The conditions for neutral protease hydrolysis were: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, and time 1 h; Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ① First, remove macromolecules using a 3 kDa ultrafiltration membrane; ② Then fractionate using a 1 kDa ultrafiltration membrane; collect the fractions smaller than 1 kDa; The obtained yak bone collagen peptides have a molecular weight of less than 1000 Da; the proportion of peptides with a molecular weight of less than 1000 Da is ≥90%. Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a concentration less than 1000 Da is reacted with calcium chloride salt and strontium lactate salt to allow the exposed natural active sites to react with Ca. 2+ 、Sr 2+The reaction conditions were as follows: yak bone collagen peptide solution mass concentration 5%; pH 6.8-7.2; temperature 50℃; time 60 min; mass ratio of yak bone collagen peptide, calcium salt, and strontium salt was yak bone collagen peptide: calcium salt: strontium salt = 100:25:2; after the reaction was completed, unbound or free calcium ions and strontium ions were removed to obtain a complex solution. Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
[0030] Comparative Example 2 A method for preparing yak bone collagen peptides for osteoporosis prevention includes the following steps: Step 1, Yak bone pretreatment: Take the long bones, ribs and spine of the yak, clean them to remove blood and impurities, and crush the yak bones to 1-3 cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; the degreasing treatment is carried out by hot water degreasing, and the hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. The acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h. After demineralization, the bones are washed with deionized water until they are close to neutral. Step 4, thermal denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water, add trehalose as a protective agent, and carry out thermal denaturation treatment; the thermal denaturation treatment conditions are: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5, and the amount of trehalose added is 3.0% w / v. Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400 W, time 30 min, temperature control not higher than 60℃. Step 6, Stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8% and perform stepwise enzymatic hydrolysis; ①The alkaline protease hydrolysis conditions were: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ②The conditions for neutral protease hydrolysis were: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, and time 1 h; Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ① First, remove macromolecules using a 3 kDa ultrafiltration membrane; ② Then fractionate using a 1 kDa ultrafiltration membrane; collect the fractions smaller than 1 kDa; The obtained yak bone collagen peptides have a molecular weight of less than 1000 Da; the proportion of peptides with a molecular weight of less than 1000 Da is ≥90%. Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a Da content less than 1000 is reacted with calcium chloride salt to allow the exposed natural active sites to react with Ca. 2+ The reaction conditions were as follows: yak bone collagen peptide solution mass concentration 5%; pH 6.8-7.2; temperature 50℃; time 60 min; mass ratio of yak bone collagen peptide to calcium salt was yak bone collagen peptide: calcium salt = 100:27; after the reaction was completed, unbound or free calcium ions were removed to obtain the complex solution. Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
[0031] Comparative Example 3 A method for preparing yak bone collagen peptides for osteoporosis prevention includes the following steps: Step 1, Yak bone pretreatment: Take the long bones, ribs and spine of the yak, clean them to remove blood and impurities, and crush the yak bones to 1-3 cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; the degreasing treatment is carried out by hot water degreasing, and the hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. The acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h. After demineralization, the bones are washed with deionized water until they are close to neutral. Step 4, thermal denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water, add trehalose as a protective agent, and carry out thermal denaturation treatment; the thermal denaturation treatment conditions are: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5, and the amount of trehalose added is 3.0% w / v. Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400 W, time 30 min, temperature control not higher than 60℃. Step 6, Stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8% and perform stepwise enzymatic hydrolysis; ①The alkaline protease hydrolysis conditions were: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ②The conditions for neutral protease hydrolysis were: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, and time 1 h; Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ① First, remove macromolecules using a 3 kDa ultrafiltration membrane; ② Then fractionate using a 1 kDa ultrafiltration membrane; collect the fractions smaller than 1 kDa; The obtained yak bone collagen peptides have a molecular weight of less than 1000 Da; the proportion of peptides with a molecular weight of less than 1000 Da is ≥90%. Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a concentration less than 1000 Da is reacted with strontium lactate to allow the exposed natural active sites to react with Sr. 2+ The reaction conditions were as follows: 5% mass concentration of yak bone collagen peptide solution; pH 6.8-7.2; temperature 50℃; time 60 min; mass ratio of yak bone collagen peptide to strontium salt was 100:27; after the reaction was completed, unbound or free strontium ions were removed to obtain the complex solution. Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
[0032] Performance testing: (a) Anti-osteoporosis test of yak bone collagen peptides.
[0033] The yak bone collagen peptide powders prepared in Examples 1-3 and Comparative Examples 1-3 were subjected to anti-osteoporosis tests.
[0034] 1. Sample preparation: Yak bone collagen peptides prepared in Examples 1-3 and Comparative Examples 1-3 were prepared using ultrapure water as the solvent.
[0035] 2. Laboratory animals: Zebrafish were raised in aquarium water at 28℃ (water quality: 200mg of instant sea salt added per 1L of reverse osmosis water, conductivity 450-550µS / cm; pH 6.5-8.5; hardness 50; 100 mg / L CaCO3). The laboratory animal use license number was SYXK (Zhejiang) 2022-0004. The husbandry and management met the requirements of the international AAALAC certification (certification number: 001458). The IACUC ethics review number was IACUC-2025-202511110008-01.
[0036] 3. Reagents: Dexamethasone (batch number L2318361, Shanghai Aladdin Biochemical Technology Co., Ltd., China); Dimethyl sulfoxide (DMSO, batch number I2229063, Shanghai Aladdin Biochemical Technology Co., Ltd., China).
[0037] 4. Maximum Detectable Concentration (MTC) Determination: Wild-type AB strain zebrafish, 3 days post-fertilization (3 dpf), were randomly selected and placed in beakers, with 30 zebrafish per beaker (experimental group). The samples were administered via water-soluble administration. A normal control group and a model control group were also established, with each beaker containing 20 mL. Except for the normal control group, all other experimental groups were administered dexamethasone via water-soluble administration to establish a zebrafish osteoporosis model. After treatment at 28℃ for 4 days, the mean chromosomal concentration (MTC) of the samples in the model zebrafish was measured.
[0038] The MTC of the yak bone collagen peptides prepared in Examples 1-3 and Comparative Examples 1-3 against model zebrafish was determined to be 250 µg / mL. The anti-osteoporosis effect was then evaluated using a concentration of 250 µg / mL.
[0039] 5. Experimental design for osteoporosis prevention: Wild-type AB strain zebrafish (3 dpf) were randomly selected and placed in beakers, with 30 zebrafish per beaker (experimental group). The samples were administered water-soluble solutions, and a normal control group and a model control group were also set up. Each beaker had a volume of 20 mL. Except for the normal control group, all other experimental groups were administered water-soluble dexamethasone to establish a zebrafish osteoporosis model. After treatment at 28℃ for 4 days, zebrafish from each experimental group were collected and stained with alizarin red. After staining, 10 zebrafish from each experimental group were randomly selected and photographed under a fluorescence microscope. Image processing software was used to analyze and collect data. The fluorescence intensity of the zebrafish skull was analyzed and statistically analyzed. The anti-osteoporosis efficacy of the samples was evaluated based on the statistical analysis results of this index. Statistical results are expressed as mean ± SE. Statistical analysis was performed, and p < 0.05 indicated statistical significance.
[0040] 6. Results of osteoporosis resistance test ( Figure 1 (and Table 1): Table 1. Fluorescence intensity of zebrafish skulls
[0041] Depend on Figure 1 As shown in Table 1, the fluorescence intensity of Examples 1-3 remained stable at approximately 108,000 pixels, an increase of approximately 13,000 pixels compared to the model control group, representing an improvement of 13.72%-13.86%, and a recovery rate of approximately 68.47%-69.17% for bone loss. This indicates that the yak bone collagen peptides prepared in this invention have a strong bone mineralization promoting effect.
[0042] The skull fluorescence intensity of Comparative Example 1 was 99876±2598, an increase of 4974 pixels compared to the model group, representing an improvement of 5.24%, indicating a certain degree of improvement in bone mineralization. However, the improvement in Comparative Example 1 was only 26.15% of the difference between the normal group and the model group, significantly lower than the approximately 68%-69% recovery level of Examples 1-3. The skull fluorescence intensity of Comparative Example 2 was 97234±2683, an increase of only 2332 pixels compared to the model group, representing an improvement of 2.46%, with an improvement of approximately 12.26% in bone loss. This indicates that Comparative Example 2 had a weak effect on restoring the mineralization level of the zebrafish skull and did not show a significant statistical difference. The skull fluorescence intensity of Comparative Example 3 was 95891±2712, an increase of only 989 pixels compared to the model group, representing an improvement of 1.04%, with an improvement of only about 5.20% in bone loss, basically close to the model control group. This indicates that Comparative Example 3 had almost no significant improvement effect on the decline in zebrafish bone mineralization.
[0043] (ii) Anti-osteoporosis test of yak bone collagen peptide composition.
[0044] The yak bone collagen peptide powders prepared in Examples 1-3 and Comparative Examples 1-3 were mixed with excipients to form a composition, which was then subjected to an anti-osteoporosis test. The composition formulation (by weight) was as follows: 30 parts yak bone collagen peptides, 12 parts isomaltooligosaccharide, 5 parts resistant dextrin, 5 parts erythritol, 1 part citric acid, 1 part vitamin D3, and 1 part vitamin K2.
[0045] 1. Bone calcium and bone mineral density tests: Female SD rats were selected and ovariectomized to establish an osteoporosis rat model. The rats weighed 260±5g. After a one-week acclimatization period, they were separated into different cages and housed for four weeks, fed the same basal diet and given deionized water. Body length and weight were measured weekly. The rats were divided into eight groups: six experimental groups, one normal control group, and one model control group, with six rats in each group. The experimental groups were each fed 3 mL of the yak bone collagen peptide composition solution from Examples 1-3 or Comparative Examples 1-3, while the control group was fed 3 mL of distilled water. All other conditions were the same. After 90 days of continued feeding, the rats were sacrificed. The left femur was then harvested, and bone calcium content was determined by atomic absorption spectrometry. The right femur was then dissected, and bone mineral density at the midpoint and distal end of the femur was measured using a bone densitometer.
[0046] Mark the distal end and midpoint of the femur to determine the measurement points. Determining the midpoint measurement point: Measure the entire length of the femur, and draw a straight line through its midpoint along the cross-sectional direction; this is the midpoint measurement point (section). Determining the distal end measurement point: Determine the measurement point at the lowest edge of the articular groove at the distal end of the femur. Draw a straight line through this point parallel to the mark at the midpoint; this is the distal end measurement point (section). Results are as follows... Figure 2 As shown in Table 2: Table 2 Bone calcium and bone mineral density
[0047] Depend on Figure 2 As shown in Table 2, the bone calcium content of Examples 1-3 all exceeded 210 mg / g, with a recovery rate of over 85%. The recovery rate of Comparative Example 1 (without trehalose) decreased to 48.3%, but was still significantly better than the model group, indicating that the ultrasound and enzymatic hydrolysis steps preserved some activity, but the lack of trehalose protection during thermal denaturation led to damage to the active sites. The recovery rate of Comparative Example 2 was 32.1%, and that of Comparative Example 3 was 20.2%, significantly lower than that of Examples 1-3. The midpoint bone mineral density of Examples 1-3 was significantly higher than that of the model control group, with a recovery rate of 75-84%. Comparative Example 1 was significantly lower than that of Example 2, indicating that trehalose is crucial for maintaining peptide structural integrity and thus ensuring bone mineral density recovery. The bone mineral density of Comparative Example 2 remained at a low level, indicating that using calcium alone... 2+ The effect is limited. Comparative Example 3 is very similar to the model group, showing almost no improvement in bone mineral density, further illustrating the limited effectiveness of Ca2+. 2+ and Sr 2+ Key synergistic role in bone mineralization. Compared with the model control group, the distal bone mineral density of Examples 1-3 was significantly improved, while the improvement in distal bone mineral density of Comparative Examples 1-3 was limited and significantly lower than that of Examples 1-3. This indicates that the yak bone collagen peptides prepared in this invention (Examples 1-3) can significantly alleviate bone calcium loss and decreased bone mineral density caused by osteoporosis. Furthermore, the optimal synergistic anti-osteoporosis effect can be achieved when calcium ions and strontium ions are present simultaneously.
[0048] This application improves the exposure of collagen in yak bone through defatting and demineralization; through heat denaturation and trehalose protection, the collagen can be moderately expanded and maintain the activity of functional groups; through ultrasonic treatment, the collagen aggregates are further loosened, and the enzyme cleavage sites and metal-binding sites are more fully exposed; through stepwise enzymatic hydrolysis with alkaline and neutral proteases, a high proportion of small molecule collagen peptides can be obtained; and then through ultrafiltration fractionation and calcium-strontium complexation, the small molecule peptides are combined with calcium... 2+ 、Sr 2+ It forms a stable complex, thereby improving the stability of mineral elements, bioavailability, and the synergistic effect of anti-osteoporosis.
[0049] Therefore, this invention involves a complex reaction of small-molecule yak bone collagen peptides with calcium salts and strontium salts, allowing the exposed natural active sites in the peptide chains to react with the calcium salts. 2+ 、Sr 2+ The combination forms a collagen peptide-calcium-strontium complex. The three components work synergistically to promote bone formation, support bone mineralization, and improve bone metabolism. Therefore, compared to single collagen peptides or single mineral supplements, it has greater potential for anti-osteoporosis applications.
[0050] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications or equivalent substitutions can still be made to the technical solutions of the present invention, and these modifications or equivalent substitutions cannot cause the modified technical solutions to deviate from the spirit and scope of the technical solutions of the present invention.
Claims
1. A method for preparing yak bone collagen peptides for osteoporosis prevention, characterized in that, Includes the following steps: Step 1, Yak bone pretreatment: Take yak bones, wash to remove blood and impurities, and crush the yak bones to 0.5-5 cm; Step 2, Degreasing treatment: The crushed yak bones are degreased; Step 3, Demineralization treatment: The defatted yak bones are subjected to acid demineralization treatment. After demineralization, they are washed with deionized water until they are close to neutral. Step 4, heat denaturation treatment: Add the demineralized yak bone collagen raw material to deionized water, add trehalose as a protective agent, and carry out heat denaturation treatment; The heat denaturation treatment conditions were: temperature 70℃, time 1h, solid-liquid ratio 1:8, pH 6.0-7.5, and trehalose addition amount 3.0%w / v; Step 5, ultrasonic treatment: Perform ultrasonic treatment on the heat-denatured solution; ultrasonic frequency 20kHz, ultrasonic power 200-400W, time 30 min, temperature control not higher than 60℃. Step 6, stepwise enzymatic hydrolysis: Adjust the mass / volume concentration of the substrate in the solution after ultrasonic treatment to 8%, first perform alkaline protease hydrolysis, and then perform neutral protease hydrolysis; ①The alkaline protease hydrolysis conditions were: enzyme dosage 8000 U / g substrate, pH 9.5, temperature 50℃, and time 3 h; ②The conditions for neutral protease hydrolysis were: enzyme dosage 8000 U / g substrate, pH 7.5, temperature 50℃, and time 1 h; Step 7, enzyme inactivation: After enzymatic hydrolysis, inactivate the enzyme at 95℃ for 10 min; then centrifuge at 5000 r / min for 15 min and collect the supernatant. Step 8, Ultrafiltration Fractionation: The supernatant is subjected to ultrafiltration to collect peptide components with a molecular weight of less than 1000 Da; ①Removal of macromolecules via a 3 kDa ultrafiltration membrane; ② Classified via a 1 kDa ultrafiltration membrane; Collect components smaller than 1 kDa; Step 9, Metal Ion Complexation: A solution of yak bone collagen peptides with a Da content less than 1000 is reacted with calcium and strontium salts to allow the exposed natural active sites to react with the calcium ions. 2+ 、Sr 2+ After the complex reaction is completed, unbound or free calcium and strontium ions are removed to obtain a complex solution; wherein, the mass ratio of yak bone collagen peptide, calcium salt and strontium salt is yak bone collagen peptide: calcium salt: strontium salt = 100:20-60:1-10; Step 10, Concentration and Drying: The complex solution is freeze-dried to obtain yak bone collagen peptide powder; The freeze-drying conditions are as follows: pre-freezing at -80℃ for 8 hours, cold trap ≤ -55℃, vacuum 10-30Pa, drying at -30℃ for 6 hours, drying at -20℃ for 8 hours, drying at -10℃ for 6 hours, and finally a second drying at 25℃ for 6 hours.
2. The method for preparing yak bone collagen peptides for osteoporosis prevention according to claim 1, characterized in that: In step 1, the yak bone is the long bone, rib, spine, or a mixture thereof; it is broken to 1-3 cm.
3. The method for preparing yak bone collagen peptides for osteoporosis prevention according to claim 1, characterized in that, In step 2, the degreasing treatment uses hot water degreasing or ethanol-assisted degreasing. The hot water degreasing conditions are: temperature 85℃, time 2h, solid-liquid ratio 1:6; the ethanol-assisted degreasing conditions are: ethanol volume fraction 20%, temperature 50℃, time 2h. In step 3, the acid demineralization treatment conditions are: hydrochloric acid concentration 0.5 mol / L, solid-liquid ratio 1:5, temperature 25℃, time 12h.
4. The method for preparing yak bone collagen peptides for osteoporosis prevention according to claim 1, characterized in that: In step 9, the calcium salt is calcium chloride, calcium lactate, calcium gluconate, calcium citrate, or calcium acetate; the strontium salt is strontium chloride, strontium lactate, strontium gluconate, or strontium acetate.
5. The method for preparing yak bone collagen peptides for osteoporosis prevention according to claim 1, characterized in that, In step 9, the composite reaction conditions are: yak bone collagen peptide solution mass concentration 3%-6%, pH 6.8-7.2, temperature 45-55℃, time 40-60 min.
6. A yak bone collagen peptide for osteoporosis prevention, characterized in that: It is prepared by the preparation method according to any one of claims 1-5.
7. The use of the yak bone collagen peptide according to claim 6 in the preparation of an anti-osteoporosis composition.
8. A composition of yak bone collagen peptides for combating osteoporosis, characterized in that, The yak bone collagen peptide composition comprises, by weight, 10-30 parts of the yak bone collagen peptide as described in claim 6, 10-15 parts of isomaltooligosaccharide, 5-10 parts of resistant dextrin, 5-15 parts of erythritol, 0.5-2 parts of citric acid, 0.5-2 parts of vitamin D3, and 0.5-2 parts of vitamin K2.
Citation Information
Patent Citations
Compound yak bone collagen peptide powder capable of restoring human cells
CN109349419A
Mineral collagen chelates and methods of making and using same
US20070087039A1
